¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ»ý¸®Åë ¼ÛµµÇÑÀÇ¿ø Ä¡·á ¹Ù·Î¿©±â

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø, #¼Ûµµ»ý¸®ÅëÇÑÀÇ¿øÄ¡·á, #À¯»êÈÄÇѾà, #¼ÛµµÀ¯»êÈÄÇѾà, #»ý¸®ÅëÇÑÀÇ¿øÄ¡·á, #À¯»êÈÄÇѾàÄ¡·á, #¼ÛµµÀ¯»êÈÄÇѾà, #ºÎõ»ý¸®ÅëÇÑÀÇ¿ø ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø,,¼Ûµµ»ý¸®ÅëÇÑÀÇ¿øÄ¡·á,,À¯»êÈÄÇѾà,,¼ÛµµÀ¯»êÈÄÇѾà,,»ý¸®ÅëÇÑÀÇ¿øÄ¡·á,,À¯»êÈÄÇѾàÄ¡·á,,¼ÛµµÀ¯»êÈÄÇѾà,,ºÎõ»ý¸®ÅëÇÑÀÇ¿ø ¾È³çÇϼ¼¿ä. ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø ºÎõ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø ºÎõ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÀ¯»êÈÄÇѾà, ÀΰøÀ¯»êÈĸöÁ¶¸®, Àΰø¼öÁ¤, ³­ÀÓ, Ãâ»êÇѾà, ´Ù³¶¼º³­¼Ò, ³­¼Ò³¶Á¾Ä¡·á, °»³â±â»ý¸®ºÒ¼ø, Ãâ»êÈÄÇѾູ¿ë, ½ÉÇÑ»ý¸®Åë, Áú¿°³¿»õ, »ý¸®ÅëÇÑÀÇ¿ø, »êÈĺױâ, ½ÃÇè°üÂø»ó, ´Ù³¶¼º, ¿ÜÀ½ºÎ¿°Áõ, Âø»óÅÁ, »ý¸®Åë¾àÃßõ, ÀڱñÙÁ¾»ý¸®Åë, »ý¸®Àü³Ã, ³­ÀÓÇÑÀÇ¿ø, »ý¸®ÅëÄ¡·á, ÀڱñÙÁ¾¼ö¼úÈÄȸº¹, »êÈÄ°ü¸®ÇÑÀÇ¿ø, ½ÉÇÑ»ý¸®Åëµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó Çѹæ¾ð¾îÄ¡·á, ¹Ì¿ëħ¼ú, ÇѹæÁ¤½Å¿ä¹ý, ¿äÃß°ßÀÎÄ¡·á, °æÇÇ°æ±Ù¿Â¿­¿ä¹ý, ÀåħÀü±âÀڱؼú, ³ì¿ë, ºÀ¾àħ, ¿À°ø¾àħ, Àü±âÀÚ±ØÄ¡·á, ±ÙÀ̿Ͼàħ, ¹ß¸ñº¸È£´ë, ¿µ¾ç±³À°, ¼Ò³ë½ºÆÀ, silver spike point, ü¿­Áø´Ü(ºÎºÐ), ¾à¹°¿ä¹ý, ¸ÆÆÄ°Ë»ç, ±â±âµµÀοä¹ý, ¼ºÀå¿îµ¿¿ä¹ý, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °­¿ø µ¿Çؽà Ã߾ϵ¿, ÀüºÏ ¹«ÁÖ±º ¹«Ç³¸é, ÀÎõ ¿¬¼ö±¸ µ¿Ãᵿ, °æºÏ »óÁֽà ÀºÃ´¸é, Ãæ³² ºÎ¿©±º ÃÊÃ̸é, °æºÏ Ä¥°î±º ¾à¸ñ¸é, °­¿ø ȫõ±º ³»¸é, °æ±â ¾È¼º½Ã °¡»çµ¿, °æ±â ºÎõ½Ã ¿ø¹Ì±¸ ¿ª°î2µ¿, ºÎ»ê ¿µµµ±¸ ¿µ¼±µ¿4°¡, °­¿ø Æòⱺ ¿ëÆò¸é, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¹Ú´Þ2µ¿, ÀÎõ ¼­±¸ ¸¶Àüµ¿, °æ³² °í¼º±º ¸¶¾Ï¸é, Àü³² ½Å¾È±º ½ÅÀǸé, °æ±â ¿ëÀνà óÀα¸ ¿ëÀοìü±¹»ç¼­ÇÔ, Àü³² ³ªÁֽà ¼®Çöµ¿, ÀüºÏ ±º»ê½Ã ³ªÆ÷¸é, °æ±â ¾çÁֽà ¿ÁÁ¤µ¿, °æºÏ °æ»ê½Ã ÇϾçÀ¾, ¿ï»ê ºÏ±¸ Á¤ÀÚµ¿, ÀüºÏ Áø¾È±º ¸¶·É¸é, ºÎ»ê Áß±¸ ±¤º¹µ¿1°¡, ºÎ»ê µ¿±¸ ¹üÀÏ5µ¿, °æ±â °¡Æò±º °¡ÆòÀ¾, Àü³² ¸ñÆ÷½Ã ºÎÁÖµ¿, ºÎ»ê ¿µµµ±¸ ³²Ç×µ¿2°¡, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ÁøÀü¸é, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ »êÈ£µ¿, °æ³² â¿ø½Ã ¸¶»êȸ¿ø±¸ ³»¼­À¾, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿øÄ¡·á ãÀ¸½Ã´Â Áß±¸, µ¿±¸, µµ¸²µ¿, ÀÎõ¼­±¸, µµÈ­µ¿, ºÎõ, ¿ëÇöµ¿, ºñºÀ¸é, °¡Á¤µ¿, ¿¬Èñµ¿, ¼®³²µ¿, ÀÎõ, ¸Å¼Û¸é, ¸¸¼öµ¿, ¼Û¸²µ¿, ¿î¼­µ¿, ³²¾çÀ¾, °Ë´Ü, °¡Áµ¿, ÆÈź¸é, ºÀ´ãÀ¾, ¿Á·Ãµ¿, °Ë¾Ï, ÀÎõ³íÇö, ¿ëÀ¯µµ, µ¿ÀÎõ, ¼­Ã¢µ¿, ÀÎõÁÖ¾È, Áßµ¿, ¼þÀǵ¿, ³íÇö°íÀܵ¿, °£¼®µ¿, ¿¬¼öµ¿, ÀÎõ³íÇöµ¿, °è¾ç±¸ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Nnoaham KE, Webster P, Kumbang J, et al. Is early age at menarche a risk factor for endometriosis? A systematic review and meta-analysis of case-control studies. Fertil Steril 2012; 98:702. 2. Pandey S, Maheshwari A, Bhattacharya S. Should access to fertility treatment be determined by female body mass index? Hum Reprod 2010; 25:815. 3. Goldstein DP, deCholnoky C, Emans SJ, Leventhal JM. Laparoscopy in the diagnosis and management of pelvic pain in adolescents. J Reprod Med 1980; 24:251. 4. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol 2006; 108:428. 5. Marjoribanks J, Proctor M, Farquhar C, Derks RS. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2010; :CD001751. 6. Reese KA, Reddy S, Rock JA. Endometriosis in an adolescent population: the Emory experience. J Pediatr Adolesc Gynecol 1996; 9:125. 7. Di Paola V, Manfredi R, Castelli F, et al. Detection and localization of deep endometriosis by means of MRI and correlation with the ENZIAN score. Eur J Radiol 2015; 84:568. 8. Steed H, Chapman W, Laframboise S. Endometriosis-associated ovarian cancer: a clinicopathologic review. J Obstet Gynaecol Can 2004; 26:709. 9. Vercellini P, Somigliana E, Consonni D, et al. Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction. Hum Reprod 2012; 27:3450. 10. Cheng YM, Wang ST, Chou CY. Serum CA-125 in preoperative patients at high risk for endometriosis. Obstet Gynecol 2002; 99:375.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ»ý¸®Åë ¼ÛµµÇÑÀÇ¿ø Ä¡·á ¹Ù·Î¿©±â""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõÇÑÀÇ¿øÃßõ ¼ÛµµÀßÇϴ°÷ ¾ðÁ¦³ª Æí¾ÈÇÑ°÷
´ÙÀ½±Û ÀÎõÇѹæ´ÙÀ̾îÆ® ±¸¿ùµ¿ÇÑÀÇ¿ø ±Ã±ÝÇØ¿ä
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
952 ´ÙÀ̾îÆ®ÇÑÀÇ¿ø »õÇØ À̺¥Æ® ÁøÇà ´ÙÀ̾îÆ®ÇÑ¾à ±¸ÀÔ Æ÷ÀÎÆ® Á¦°ø 0 240 2024-01-15
951 ÀÌõ±³Åë»ç°íÇÑÀÇ¿ø Ãʱ⠰ü¸®·Î ÈÄÀ¯Áõ ¿¹¹æÇØ¿ä 3 487 2023-10-14
950 ÆíµÎÅë ¿¹¹æ¾à ó¹æ, ÁøÅëÁ¦¿Í ÇѾà Ä¡·á ¾Ë¾Æº¸±â 0 473 2023-10-13
949 ¸Þ´Ï¿¡¸£º´ Áø´Ü ¹Þ¾Ò´Ù¸é ¾çÀç µÎûÇÑÀÇ¿øÀ¸·Î 0 520 2023-10-13
948 »êº»±³Åë»ç°íÇÑÀÇ¿ø Ä¡·á¸¸Á·µµ ³ôÀº ÀÌÀ¯ 0 613 2023-08-18
947 â¿ø ÇѾàÀßÁþ´Â°÷ À¯¾Ø¹ÌÇÑÀÇ¿ø 2 983 2023-06-02
946 [ÆíµÎÅëÄ®·³2ź]µÎûÇÑÀÇ¿ø, ÆíµÎÅëÀÌ Ä¡·á°¡ ¾ÈµÇ´Â ÀÌÀ¯ 0 783 2023-05-23
945 [ÆíµÎÅëÄ®·³1ź]µÎûÇÑÀÇ¿ø, ÆíµÎÅëÀ» ¾Î´ø ÇÑÀÇ»ç ÆíµÎÅëÀ» ¿ÏÄ¡ÇÏ´Ù 3 833 2023-05-19
944 â¿ø ¸¶»ê ´ß»ìÇǺΠ¸ð°ø°¢È­Áõ ÇÑÀÇ¿ø Ä¡·á·Î ½Î¾Ç~ 2 795 2023-05-11
943 ºÎ»ê¼­¸é´ÙÀ̾îÆ®ÇÑÀÇ¿ø »ýÈ°°Ç°­ÇÑÀÇ¿ø 5¿ù °¡Á¤ÀÇ´Þ Æ¯°¡À̺¥Æ® ½ÃÀÛ.. 3 1,059 2023-05-10
942 ±¸¿ùµ¿ÇÑÀÇ¿ø °æÈñÀÚ¶õÇÑÀÇ¿ø¿¡¼­ ´ÙÀ̾îÆ® ±³Åë»ç°í Ãß³ª¿ä¹ý ÀÎõ ³².. 2 961 2023-05-10
941 â¿ø´ÙÀ̾îÆ®ÇÑÀÇ¿ø, â¿ø´ÙÀ̾îƮȯ À¯¾Ø¹ÌÇÑÀÇ¿ø ½½¸²È¯ 2 929 2023-04-20
940 ûÁÖ º¹´ëµ¿ ÇÑÀÇ¿ø, ¸¶À½¿¡²ÉÇÑÀÇ¿ø º½¸ÂÀÌ À̺¥Æ® 18 1,032 2023-04-19
939 ¿µµîÆ÷ÇÑÀÇ¿ø ¼±ÇÑÀÇ¿ø Áñ°Å¿ö º½ À̺¥Æ® 14 940 2023-04-19
938 â¿ø ¸¶»ê ´ÙÀ̾îƮȯ À¯¾Ø¹ÌÇÑÀÇ¿ø 12 1,383 2023-03-20
937 â¿ø ¸¶»ê»êÈĺ¸¾à Çѹ泻°úÀü¹®ÀÇ °Ç°­ÇÑ È¸º¹ 14 1,156 2023-02-02
936 [¶óÀ²ÇÑÀÇ¿ø] º½À» ±â´Ù¸®´Â 2¿ù À̺¥Æ® 0 1,348 2023-02-02
935 ÇØ¿ÂÇÑÀÇ¿ø ¼³³¯À̺¥Æ® °øÁø´Ü °æ¿Á°í ½ÖÈ­ÅÁ ÇýÅà (~1/31) 1 1,030 2023-01-10
934 ÇÏÀÌÅ°ÇÑÀÇ¿ø 1¿ù À̺¥Æ® ¾È³» 0 1,232 2023-01-03
933 ¸¶ÀÌÇÃÇÑÀÇ¿ø ¿¬¸» °¨»ç À̺¥Æ® 0 1,614 2022-12-09
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷